Caption Management, LLC Arcellx, Inc. Put Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2025 Aug 14, 2025	BUY	$52.8 - $68.1 $12.6 Million - $16.3 Million	238,800 Added 197.03%	360,000 $23.7 Million
Q1 2025 May 15, 2025	SELL	$60.26 - $79.13 $8.88 Million - $11.7 Million	-147,400 Reduced 54.88%	121,200 $7.95 Million
Q4 2024 Feb 14, 2025	SELL	$75.39 - $106.53 $18.9 Million - $26.7 Million	-251,000 Reduced 48.31%	268,600 $20.5 Million
Q3 2024 Nov 14, 2024	BUY	$50.91 - $86.61 $26.5 Million - $45 Million	519,600 New	519,600 $43.4 Million
Q4 2023 Feb 14, 2024	BUY	$31.75 - $57.99 $793,750 - $1.45 Million	25,000 New	25,000 $1.39 Million
Q1 2023 May 15, 2023	BUY	$26.92 - $33.94 $336,500 - $424,250	12,500 New	12,500 $385,000

222

49.1M

245K

885K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.75B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.